BioNukleo will present his enzymatic technology for the production of modified nucleosides and nucleotides on the Peptalk which takes places January 8-12, 2018 in San Diego. 

 

BioNukleo was presenting at MedChem 2017 with the topic „The Many Pharmacotherapeutic Faces of Nucleosides and Oligonucleotides” in Leuven on December 1st 2017

The objective of the one-day symposium was to show recent developments for the applications of nucleosides, nucleotides and nucleic acids in medicinal chemistry. Applications are still found in the fields of antivirals, anticancer compounds or antisense oligonucleotides. But also new therapeutic applications are found like in immune-oncology, which opens many new possibilities. Prof. Jens Kurreck, Coach of the BioNukleo  Team, presented BioNukleo's sustainable technology which can be used for the production of nucleosides and nucleotides.

 

BioNukleo presented at MDC-Berlin

 

Katharina Paulick, one of BioNukleo's CEOs, gave a talk at the `Career Day' of the Max Delbrück Centre for molecular medicine in Berlin. Encouraging PhD students to get entrepreneurs, she talked about first steps founding a startup and about financing possibilities. Also her own career as a scientist and entrepreneur was in focus. Subsequent, she made contact to the 3Is Pharma Innovation Initiative and will show them how BioNukleo was founded, funded and growing. As BioNukleo got and gets much advice from coaches and other companies, it is important to keep young students informed about the startup scene in Germany.

BioNukleo is part of the Network for Pharma Solutions -NetPhaSol 

 

 

We proudly announce the start of „Network for Pharma Solutions – NetPhaSol“. This cooperation network for drug development serves as a platform for research, development and marketing of new products, processes and services. The primary focus are the first value chain stages of a drug development cycle - however, further development stages are not excluded. BioNukleo is now broadening NetPhaSol´s profile with its expertise in Drug development. The initiative will present its portfolio at the drug development meeting „Treffpunkt Wirkstoffentwicklung“ on 16th October in Berlin. More information you can find here.

 

Source: Berlin Partner for Business and Technology GmbH

 

BioNukleo was at "1st Symposium on Nucleic Acid Modifications" in Mainz 4- 6 September 2017

Most of the symposium was dedicated to plenary lectures from invited speakers as well as short talks. There also were poster sessions where selected participants could present their research. The schedule also included social activities, such as a welcome reception/dinner, lunch and coffee breaks as well as a guided city tour.

BioNukleo at Bionnale

Consectetur adipiscing elit. Inscite autem medicinae et gubernationis ultimum cum ultimo sapientiae comparatur.

BioNukleo at German Biotechnology days

Consectetur adipiscing elit. Inscite autem medicinae et gubernationis ultimum cum ultimo sapientiae comparatur.

Label "Innovative through research"

From the german "Stifterverband", BioNukleo gets the label "Innovative through research due to it's high expenses in biocatalytic research.


BioNukleo was at BioTechnika

Together with Labvolution, the Biotechnika was in May 16-18 in Hannover, Germany. The specialist trade fair for innovative lab equipment and laboratory workflow optimization "LABVOLUTION with Life Science Event BIOTECHNICA" has a new thematic focus. BioNukleo made contact to customers, distributers and had a close look at the new smart lab- showing the future of molecular biology. In fact, BioNukleo has also access to the lab of the future from the TU Berlin, with different robots facilitation scientist´s work.